The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Prospective of 68Ga-Radiopharmaceutical Development
Open accessAbstract
Positron Emission Tomography (PET) experienced accelerated development and has become an established method for medical research and clinical routine diagnostics on patient individualized basis. Development and availability of new radiopharmaceuticals specific for particular diseases is one of the driving forces of the expansion of clinical PET. The future development of the ⁶⁸Ga-radiopharmaceuticals must be put in the context of several aspects such as role of PET in nuclear medicine, unmet medical needs, identification of new biomarkers, targets and corresponding ligands, production and availability of ⁶⁸Ga, automation of the radiopharmaceutical production, progress of positron emission tomography technologies and image analysis methodologies for improved quantitation accuracy, PET radiopharmaceutical regulations as well as advances in radiopharmaceutical chemistry. The review presents the prospects of the ⁶⁸Ga-based radiopharmaceutical development on the basis of the current status of these aspects as well as wide range and variety of imaging agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777
Gastroenteropancreatic neuroendocrine tumours
Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., Caplin, M., Delle Fave, G., Kaltsas, G. A., Krenning, E. P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70410-2 · Cited by 1,748
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
Boellaard, R., O’Doherty, M. J., Weber, W. A., Mottaghy, F. M., Lonsdale, M. N., Stroobants, S. G., Oyen, W. J. G., Kotzerke, J., Hoekstra, O. S., Pruim, J., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1297-4 · Cited by 1,326
Reubi, J. C., Schär, J.-C., Waser, B., Wenger, S., Heppeler, A., Schmitt, J. S., & Mäcke, H. R. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050034 · Cited by 1,127
Afshar-Oromieh, A., Malcher, A., Eder, M., Eisenhut, M., Linhart, H. G., Hadaschik, B. A., Holland-Letz, T., Giesel, F. L., Kratochwil, C., Haufe, S., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2298-2 · Cited by 915
68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
Eder, M., Schäfer, M., Bauder-Wüst, U., Hull, W.-E., Wängler, C., Mier, W., Haberkorn, U., & Eisenhut, M. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200279b · Cited by 843
PET versus SPECT: strengths, limitations and challenges
Rahmim, A., & Zaidi, H. (2008) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3282f3a515 · Cited by 834
British Journal of Clinical Pharmacology
(2010) · British Journal of Clinical Pharmacology · doi:10.1111/(issn)1365-2125 · Cited by 833
Kayani, I., Bomanji, J. B., Groves, A., Conway, G., Gacinovic, S., Win, T., Dickson, J., Caplin, M., & Ell, P. J. (2008) · Cancer · doi:10.1002/cncr.23469 · Cited by 477
Virgolini, I., Ambrosini, V., Bomanji, J. B., Baum, R. P., Fanti, S., Gabriel, M., Papathanasiou, N. D., Pepe, G., Oyen, W., De Cristoforo, C., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1512-3 · Cited by 442
European Journal of Nuclear Medicine and Molecular Imaging
(2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/259.1619-7089 · Cited by 430
68Ga-DOTATOC Versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine Tumors
Poeppel, T. D., Binse, I., Petersenn, S., Lahner, H., Schott, M., Antoch, G., Brandau, W., Bockisch, A., & Boy, C. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.091165 · Cited by 346
Afshar-Oromieh, A., Haberkorn, U., Eder, M., Eisenhut, M., & Zechmann, C. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2069-0 · Cited by 325
Bergstr�m, M., Grahn�n, A., & L�ngstr�m, B. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0643-x · Cited by 311
Srirajaskanthan, R., Kayani, I., Quigley, A. M., Soh, J., Caplin, M. E., & Bomanji, J. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.066134 · Cited by 310
Baum, R. P., Prasad, V., Müller, D., Schuchardt, C., Orlova, A., Wennborg, A., Tolmachev, V., & Feldwisch, J. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.073239 · Cited by 308
Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors
Smith-Jones, P. M., Solit, D. B., Akhurst, T., Afroze, F., Rosen, N., & Larson, S. M. (2004) · Nature Biotechnology · doi:10.1038/nbt968 · Cited by 304
Bartholomä, M. D., Louie, A. S., Valliant, J. F., & Zubieta, J. (2010) · Chemical Reviews · doi:10.1021/cr1000755 · Cited by 298
Hwang, D. W., Ko, H. Y., Lee, J. H., Kang, H., Ryu, S. H., Song, I. C., Lee, D. S., & Kim, S. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.069880 · Cited by 293
Radiolabelling DOTA-peptides with 68Ga
Breeman, W. A. P., de Jong, M., de Blois, E., Bernard, B. F., Konijnenberg, M., & Krenning, E. P. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1702-y · Cited by 291
Baum, R. P., & Kulkarni, H. R. (2012) · Theranostics · doi:10.7150/thno.3645 · Cited by 283
Ambrosini, V., Tomassetti, P., Castellucci, P., Campana, D., Montini, G., Rubello, D., Nanni, C., Rizzello, A., Franchi, R., & Fanti, S. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0769-2 · Cited by 266
Fani, M., Del Pozzo, L., Abiraj, K., Mansi, R., Tamma, M. L., Cescato, R., Waser, B., Weber, W. A., Reubi, J. C., & Maecke, H. R. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.087999 · Cited by 262
Hybrid PET/MRI of Intracranial Masses: Initial Experiences and Comparison to PET/CT
Boss, A., Bisdas, S., Kolb, A., et al. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.074773 · Cited by 261
Hofman, M. S., Kong, G., Neels, O. C., Eu, P., Hong, E., & Hicks, R. J. (2012) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/j.1754-9485.2011.02327.x · Cited by 251
(68)Ga-labeled peptides in tumor imaging.
Maëcke, H. R., Hofmann, M., & Haberkorn, U. (2005) · PubMed · Cited by 242
Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs
LAPPIN, G., KUHNZ, W., JOCHEMSEN, R., KNEER, J., CHAUDHARY, A., OOSTERHUIS, B., DRIJFHOUT, W., ROWLAND, M., & GARNER, R. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.05.008 · Cited by 241
Haug, A. R., Auernhammer, C. J., Wängler, B., Schmidt, G. P., Uebleis, C., Göke, B., Cumming, P., Bartenstein, P., Tiling, R., & Hacker, M. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.075002 · Cited by 231
PET of CXCR4 Expression by a 68Ga-Labeled Highly Specific Targeted Contrast Agent
Gourni, E., Demmer, O., Schottelius, M., D'Alessandria, C., Schulz, S., Dijkgraaf, I., Schumacher, U., Schwaiger, M., Kessler, H., & Wester, H.-J. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.098798 · Cited by 228
Frilling, A., Sotiropoulos, G. C., Radtke, A., Malago, M., Bockisch, A., Kuehl, H., Li, J., & Broelsch, C. E. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181fd37e8 · Cited by 222
68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer
Banerjee, S. R., Pullambhatla, M., Byun, Y., Nimmagadda, S., Green, G., Fox, J. J., Horti, A., Mease, R. C., & Pomper, M. G. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100623e · Cited by 213
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours
Mansi, R., Wang, X., Forrer, F., Waser, B., Cescato, R., Graham, K., Borkowski, S., Reubi, J. C., & Maecke, H. R. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1596-9 · Cited by 205
Hong, H., Zhang, Y., Engle, J. W., Nayak, T. R., Theuer, C. P., Nickles, R. J., Barnhart, T. E., & Cai, W. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.031 · Cited by 204
Radiopeptide Imaging and Therapy in Europe
Ambrosini, V., Fani, M., Fanti, S., Forrer, F., & Maecke, H. R. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.085753 · Cited by 201
Improved 18F Labeling of Peptides with a Fluoride-Aluminum-Chelate Complex
McBride, W. J., D’Souza, C. A., Sharkey, R. M., Karacay, H., Rossi, E. A., Chang, C.-H., & Goldenberg, D. M. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100137x · Cited by 200
Role of Somatostatins in Gastroenteropancreatic Neuroendocrine Tumor Development and Therapy
Öberg, K. E., Reubi, J., Kwekkeboom, D. J., & Krenning, E. P. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.002 · Cited by 200
PET Imaging of CXCR4 Receptors in Cancer by a New Optimized Ligand
Demmer, O., Gourni, E., Schumacher, U., Kessler, H., & Wester, H. (2011) · ChemMedChem · doi:10.1002/cmdc.201100320 · Cited by 198
Jeong, J. M., Hong, M. K., Chang, Y. S., Lee, Y., Kim, Y. J., Cheon, G. J., Lee, D. S., Chung, J., & Lee, M. C. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.047423 · Cited by 197
Molecular imaging targeting peptide receptors
Schottelius, M., & Wester, H.-J. (2009) · Methods · doi:10.1016/j.ymeth.2009.03.012 · Cited by 194
Milker-Zabel, S., Bois, A. Z.-D., Henze, M., et al. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.12.006 · Cited by 190
PET/CT imaging in different types of lung cancer: An overview
Ambrosini, V., Nicolini, S., Caroli, P., Nanni, C., Massaro, A., Marzola, M. C., Rubello, D., & Fanti, S. (2012) · European Journal of Radiology · doi:10.1016/j.ejrad.2011.03.020 · Cited by 190
68Ga-labeled multimeric RGD peptides for microPET imaging of integrin αvβ3 expression
Li, Z.-B., Chen, K., & Chen, X. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0692-y · Cited by 190
Standardized Uptake Values of 68Ga-DOTANOC PET: A Promising Prognostic Tool in Neuroendocrine Tumors
Campana, D., Ambrosini, V., Pezzilli, R., Fanti, S., Labate, A. M. M., Santini, D., Ceccarelli, C., Nori, F., Franchi, R., Corinaldesi, R., et al. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.066662 · Cited by 183
First Clinical Evidence That Imaging with Somatostatin Receptor Antagonists Is Feasible
Wild, D., Fani, M., Behe, M., Brink, I., Rivier, J. E. F., Reubi, J. C., Maecke, H. R., & Weber, W. A. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.088922 · Cited by 183
Gallium(III) Complexes of DOTA and DOTA−Monoamide: Kinetic and Thermodynamic Studies
Kubíček, V., Havlíčková, J., Kotek, J., Tircsó, G., Hermann, P., Tóth, É., & Lukeš, I. (2010) · Inorganic Chemistry · doi:10.1021/ic101378s · Cited by 176
Dijkgraaf, I., Rijnders, A. Y., Soede, A., Dechesne, A. C., van Esse, G. W., Brouwer, A. J., Corstens, F. H. M., Boerman, O. C., Rijkers, D. T. S., & Liskamp, R. M. J. (2007) · Organic & Biomolecular Chemistry · doi:10.1039/b615940k · Cited by 174
Early tumor response to Hsp90 therapy using HER2 PET: comparison with 18F-FDG PET.
Smith-Jones, P. M., Solit, D. B., Afroze, F., Rosen, N. X., & Larson, S. M. (2006) · PubMed · Cited by 173
Unexpected Sensitivity of sst2 Antagonists to N-Terminal Radiometal Modifications
Fani, M., Braun, F., Waser, B., Beetschen, K., Cescato, R., Erchegyi, J., Rivier, J. E., Weber, W. A., Maecke, H. R., & Reubi, J. C. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.102764 · Cited by 172
Is there still a role for SPECT–CT in oncology in the PET–CT era?
Hicks, R. J., & Hofman, M. S. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.188 · Cited by 165
Rominger, A., Saam, T., Vogl, E., Übleis, C., la Fougère, C., Förster, S., Haug, A., Cumming, P., Reiser, M. F., Nikolaou, K., et al. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.070672 · Cited by 159
Dumont, R. A., Deininger, F., Haubner, R., Maëcke, H. R., Weber, W., & Fani, M. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.087700 · Cited by 157
Exendin-4–Based Radiopharmaceuticals for Glucagonlike Peptide-1 Receptor PET/CT and SPECT/CT
Wild, D., WICKI, A. N., Mansi, R., Béhé, M. P., Keil, B. R., Bernhardt, P., Christofori, G., Ell, P. J., & Mäcke, H. R. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.074914 · Cited by 155
Kabasakal, L., Demirci, E., Ocak, M., Decristoforo, C., Araman, A. O., Özsoy, Y., Uslu, İ., & Kanmaz, B. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2123-y · Cited by 153
The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials
Marchetti, S., & Schellens, J. H. M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603925 · Cited by 152
Beauregard, J., Hofman, M. S., Kong, G., & Hicks, R. J. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1937-3 · Cited by 151
Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody
Sharkey, R. M., Cardillo, T. M., Rossi, E. A., Chang, C., Karacay, H., McBride, W. J., Hansen, H. J., Horak, I. D., & Goldenberg, D. M. (2005) · Nature Medicine · doi:10.1038/nm1322 · Cited by 148
18F, 64Cu, and 68Ga Labeled RGD-Bombesin Heterodimeric Peptides for PET Imaging of Breast Cancer
Liu, Z., Yan, Y., Liu, S., Wang, F., & Chen, X. S. (2009) · Bioconjugate Chemistry · doi:10.1021/bc9000245 · Cited by 145
Goldenberg, D. M., Rossi, E. A., Sharkey, R. M., McBride, W. J., & Chang, C. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.046185 · Cited by 143
68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET
Brom, M., Oyen, W. J. G., Joosten, L., Gotthardt, M., & Boerman, O. C. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1363-y · Cited by 142
Velikyan, I., Sundin, A., Eriksson, B. K., Lundqvist, H., Sørensen, J. C. H., Bergström, M., & Långström, B. (2010) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2009.11.008 · Cited by 140
Self-citation[68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning
Gehler, B., Paulsen, F., Öksüz, M. Ö., Hauser, T., Eschmann, S. M., Bares, R., Pfannenberg, C., Bamberg, M., Bartenstein, P., Belka, C., et al. (2009) · Radiation Oncology · doi:10.1186/1748-717x-4-56 · Cited by 140
The molecular imaging approach to image infections and inflammation by nuclear medicine techniques
Signore, A., & Glaudemans, A. W. J. M. (2011) · Annals of Nuclear Medicine · doi:10.1007/s12149-011-0521-z · Cited by 139
68Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging
Liu, Z., Niu, G., Wang, F., & Chen, X. S. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1123-z · Cited by 137
Peptides and Receptors in Image-Guided Therapy: Theranostics for Neuroendocrine Neoplasms
Baum, R. P., Kulkarni, H., & Carreras, C. (2012) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2012.01.002 · Cited by 134
68Ga-Siderophores for PET Imaging of Invasive Pulmonary Aspergillosis: Proof of Principle
Petřík, M., Haas, H., Dobrozemsky, G., Lass‐Flörl, C., Helbok, A., Blatzer, M., Dietrich, H., & Decristoforo, C. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.072462 · Cited by 134
Combined PET/MRI: one step further in multimodality imaging
Sauter, A. W., Wehrl, H. F., Kolb, A., Judenhofer, M. S., & Pichler, B. J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.08.003 · Cited by 133
[68Ga]NODAGA-RGD for imaging αvβ3 integrin expression
Knetsch, P. A., Petřík, M., Griessinger, C. M., Rangger, C. A., Fani, M., Kesenheimer, C., von Guggenberg, E., Pichler, B. J., Virgolini, I. J., Decristoforo, C., et al. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1778-0 · Cited by 132
68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET
Ambrosini, V., Campana, D., Tomassetti, P., & Fanti, S. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1989-4 · Cited by 130
Bartholomä, M. D. (2012) · Inorganica Chimica Acta · doi:10.1016/j.ica.2012.01.061 · Cited by 129
Zhang, H., Schuhmacher, J., Waser, B., Wild, D., Eisenhut, M., Reubi, J. C., & Maëcke, H. R. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0347-4 · Cited by 128
Aalto, K., Autio, A. K., Kiss, E. A., Elima, K., Nymalm, Y., Veres, T. Z., Marttila‐Ichihara, F., Elovaara, H., Saanijoki, T., Crocker, P. R., et al. (2011) · Blood · doi:10.1182/blood-2010-09-311076 · Cited by 127
Boy, C., Heusner, T. A., Poeppel, T. D., Redmann-Bischofs, A., Unger, N., Jentzen, W., Brandau, W., Mann, K., Antoch, G., Bockisch, A., et al. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1760-x · Cited by 125
Somatostatin Receptors as Targets for Nuclear Medicine Imaging and Radionuclide Treatment
Maëcke, H. R., & Reubi, J. C. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.084236 · Cited by 125
Dimitrakopoulou‐Strauss, A., Hohenberger, P., Haberkorn, U., Mäcke, H. R., Eisenhut, M., & Strauss, L. G. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.038091 · Cited by 124
Dijkgraaf, I., Yim, C., Franssen, G. M., Schuit, R. C., Luurtsema, G., Liu, S., Oyen, W. J. G., & Boerman, O. C. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1615-x · Cited by 123
Petřík, M., Franssen, G. M., Haas, H., Laverman, P., Hörtnagl, C., Schrettl, M., Helbok, A., Lass‐Flörl, C., & Decristoforo, C. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2110-3 · Cited by 123
Prasad, V., & Baum, R. P. (2010) · PubMed · Cited by 123
Tanaka, K., Masuyama, T., Hasegawa, K., et al. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200702989 · Cited by 122
Velikyan, I., Sundberg, Å. L., Lindhe, Ö., Höglund, A. U., Eriksson, O., Werner, E., Carlsson, J., Bergström, M., Långström, B., & Максимилианович, Т. В. (2005) · PubMed · Cited by 121
Self-citationŠimeček, J., Schulz, M., Notni, J., Plutnar, J., Kubíček, V., Havlíčková, J., & Hermann, P. (2011) · Inorganic Chemistry · doi:10.1021/ic202103v · Cited by 117
Conry, B. G., Papathanasiou, N. D., Prakash, V., Kayani, I. A., Caplin, M. E., Mahmood, S., & Bomanji, J. B. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1204-z · Cited by 116
Cescato, R., Érchegyi, J., Waser, B., Piccand, V., Maëcke, H. R., Rivier, J., & Reubi, J. C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701618q · Cited by 116
Vosjan, M. J. W. D., Perk, L. R., Roovers, R. C., Visser, G. W. M., van Walsum, M., Henegouwen, P. M. P. V. B. E., & van Dongen, G. A. M. S. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1700-1 · Cited by 116
Ambrosini, V., Nanni, C., Zompatori, M., Campana, D., Tomassetti, P., Castellucci, P., Allegri, V., Rubello, D., Montini, G. C., Franchi, R., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1349-9 · Cited by 115
Abiraj, K., Mansi, R., Tamma, M., Fani, M., Forrer, F., Nicolas, G., Cescato, R., Reubi, J. C., & Maëcke, H. R. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.094375 · Cited by 114
Pretargeted Molecular Imaging and Radioimmunotherapy
Goldenberg, D. M., Chang, C., Rossi, E. A., McBride, W. J., & Sharkey, R. M. (2012) · Theranostics · doi:10.7150/thno.3582 · Cited by 109
Cescato, R., Waser, B., Fani, M., & Reubi, J. C. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.095778 · Cited by 108
Design, Synthesis, and Functionalization of Dimeric Peptides Targeting Chemokine Receptor CXCR4
Demmer, O., Dijkgraaf, I., Schumacher, U., Marinelli, L., Cosconati, S., Gourni, E., Wester, H., & Kessler, H. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2009716 · Cited by 107
Schoffelen, R., Sharkey, R. M., Goldenberg, D. M., Franssen, G. M., McBride, W. J., Rossi, E. A., Chang, C., Laverman, P., Disselhorst, J. A., Eek, A., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0862 · Cited by 101
Evaluation of Bifunctional Chelates for the Development of Gallium-Based Radiopharmaceuticals
Ferreira, C. L., Lamsa, E., Woods, M., Duan, Y., Fernando, P., Bensimon, C., Kordos, M., Guenther, K. J., Jurek, P. E., & Kiefer, G. E. (2010) · Bioconjugate Chemistry · doi:10.1021/bc900443a · Cited by 100
Selvaraju, R. K., Velikyan, I., Johansson, L., Wu, Z., Todorov, I., Shively, J. E., KANDEEL, F. R., Korsgren, O., & Eriksson, O. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.114066 · Cited by 98
Self-citationThe Next Generation of Positron Emission Tomography Radiopharmaceuticals in Oncology
Rice, S. L., Roney, C. A., Daumar, P., & Lewis, J. S. (2011) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2011.02.002 · Cited by 96
In vitro and in vivo evaluation of selected 68Ga-siderophores for infection imaging
Petřík, M., Haas, H., Schrettl, M., Helbok, A., Blatzer, M., & Decristoforo, C. (2011) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2011.09.012 · Cited by 96
68Ga-DOTA-TATE PET vs. 123I-MIBG in Identifying Malignant Neural Crest Tumours
Naji, M., Zhao, C., Welsh, S. J., Meades, R., Win, Z., Ferrarese, A., Tan, T., Rubello, D., & AL-NAHHAS, A. M. (2010) · Molecular Imaging and Biology · doi:10.1007/s11307-010-0396-8 · Cited by 95
Diagnostic nanocarriers for sentinel lymph node imaging
Jain, R. D., Dandekar, P. P., & Patravale, V. B. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.05.010 · Cited by 92
Distribution pattern of 68Ga-DOTATATE in disease-free patients
Shastry, M., Kayani, I. A., Wild, D., Caplin, M. E., Visvikis, D., Gacinovic, S., Reubi, J. C., & Bomanji, J. B. (2010) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e32833f635e · Cited by 92
Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU
Verbruggen, A., Coenen, H. H., Deverre, J.-R., Guilloteau, D., Långström, B., Salvadori, P. A., & Halldin, C. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0853-7 · Cited by 91
Optimal buffer choice of the radiosynthesis of 68Ga–Dotatoc for clinical application
Bauwens, M., Chekol, R., Vanbilloen, H. P., Bormans, G. M., & Verbruggen, A. (2010) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e32833acb99 · Cited by 85
Engineered affinity proteins for tumour‐targeting applications
Friedman, M., & Ståhl, S. (2009) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20080287 · Cited by 85
Schreiter, N. F., Brenner, W., Nogami, M., Buchert, R., Huppertz, A., Pape, U., Prasad, V., Hamm, B., & Maurer, M. H. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1935-5 · Cited by 84
Mindt, T. L., Müller, C., Stuker, F., Salazar, J.-F., Höhn, A., Mueggler, T., Rudin, M., & Schibli, R. (2009) · Bioconjugate Chemistry · doi:10.1021/bc900276b · Cited by 82
68Ga-BPAMD: PET-imaging of bone metastases with a generator based positron emitter
Fellner, M., Biesalski, B., Bausbacher, N., Kubíček, V., Hermann, P., Rösch, F., & Thews, O. (2012) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2012.04.007 · Cited by 82
Commentary: The phase 0 microdosing concept
Garner, R. C., & Lappin, G. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02575.x · Cited by 81
The importance of high specific radioactivity in the performance of 68Ga-labeled peptide
Velikyan, I., Beyer, G. J., Bergström‐Pettermann, E., Johansen, P., Bergström, M., & Långström, B. (2008) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2008.03.002 · Cited by 81
Self-citationImaging Key Biomarkers of Tumor Angiogenesis
Backer, M. V., & Backer, J. M. (2012) · Theranostics · doi:10.7150/thno.3623 · Cited by 80
Šimeček, J., Hermann, P., Wester, H., & Notni, J. (2012) · ChemMedChem · doi:10.1002/cmdc.201200471 · Cited by 78
Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors
Roosenburg, S., Laverman, P., van Delft, F. L., & Boerman, O. C. (2010) · Amino Acids · doi:10.1007/s00726-010-0501-y · Cited by 78
Haug, A. R., Rominger, A., Mustafa, M., Auernhammer, C. J., Göke, B., Schmidt, G. P., Wängler, B., Cumming, P. D., Bartenstein, P., & Hacker, M. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.089276 · Cited by 78
Wahl, R. L., Herman, J. M., & Ford, E. (2011) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.11.004 · Cited by 75
Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours
Janson, E. T., Sørbye, H., Welin, S., Federspiel, B., Grønbæk, H., Hellman, P., Mathisen, Ø., Mortensen, J., Sundin, A., Thiis‐Evensen, E., et al. (2010) · Acta Oncologica · doi:10.3109/0284186x.2010.492791 · Cited by 75
Impact of Time-of-Flight and Point-Spread-Function in SUV Quantification for Oncological PET
Prieto, E., Domínguez‐Prado, I., García‐Velloso, M. J., Peñuelas, I., Richter, J. Á., & Martí-Climent, J. M. (2013) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e318279b9df · Cited by 74
68Ga-DOTATATE PET in neuroectodermal tumours: First experience
Win, Z., AL-NAHHAS, A. M., Towey, D., et al. (2007) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e32808ea0b0 · Cited by 74
Simultaneous 68Ga-DOTATOC-PET/MRI for IMRT Treatment Planning for Meningioma: First Experience
Thorwarth, D., Henke, G., Müller, A., Reimold, M., Beyer, T., Boss, A., Kolb, A., Pichler, B. J., & Pfannenberg, C. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.10.078 · Cited by 74
Molecular Imaging and Radiotherapy: Theranostics for Personalized Patient Management
Velikyan, I. (2012) · Theranostics · doi:10.7150/thno.4428 · Cited by 73
Self-citationKnör, S., Modlinger, A., Poethko, T., Schottelius, M., Wester, H., & Kessler, H. (2007) · Chemistry - A European Journal · doi:10.1002/chem.200700231 · Cited by 73
Öberg, K. (2012) · Theranostics · doi:10.7150/thno.3931 · Cited by 72
Combined PET/MR Imaging — Technology and Applications
Wehrl, H. F., Sauter, A. W., Judenhofer, M. S., & Pichler, B. J. (2010) · Technology in Cancer Research & Treatment · doi:10.1177/153303461000900102 · Cited by 72
Radiopeptide Imaging and Therapy in the United States
Graham, M. M., & Menda, Y. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.085746 · Cited by 71
Ambrosini, V., Zompatori, M., Luca, F. D., Antonia, D., Allegri, V., Nanni, C., Malvi, D., Tonveronachi, E., Fasano, L., Fabbri, M., et al. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.079962 · Cited by 71
Imaging Expression of the Human Somatostatin Receptor Subtype-2 Reporter Gene with 68Ga-DOTATOC
Zhang, H., Moroz, M. A., Serganova, I. S., Ku, T. W., Huang, R., Vider, J., Maëcke, H. R., Larson, S. M., Blasberg, R. G., & Smith-Jones, P. M. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.079004 · Cited by 70
Versari, A., Camellini, L., Carlinfante, G., Frasoldati, A., Nicoli, F., Grassi, E., Gallo, C., Giunta, F. P., Fraternali, A., Salvo, D., et al. (2010) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3181d6677c · Cited by 67
Trends in Nuclear Medicine in Developing Countries
Dondi, M., Kashyap, R., Páez, D., Pascual, T. N. B., Zaknun, J. J., Bastos, F. M., & Pynda, Y. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.089193 · Cited by 67
Gabriel, M., Andergassen, U., Putzer, D., Kroiss, A., Waitz, D., von Guggenberg, E., Kendler, D., & Virgolini, I. J. (2010) · PubMed · Cited by 66
Feasibility and availability of 68Ga-labelled peptides
Decristoforo, C., Pickett, R. D., & Verbruggen, A. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1988-5 · Cited by 66
Status of and Trends in Nuclear Medicine in the United States
Delbeke, D., & Segall, G. M. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.085688 · Cited by 65
Novel radiolabeled antibody conjugates
Goldenberg, D. M., & Sharkey, R. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210373 · Cited by 64
Froeling, V., Elgeti, F., Maurer, M. H., Scheurig‐Muenkler, C., Beck, A., Kröncke, T. J., Pape, U., Hamm, B., Brenner, W., & Schreiter, N. F. (2012) · Annals of Nuclear Medicine · doi:10.1007/s12149-012-0634-z · Cited by 63
Sainz-Esteban, A., Prasad, V., Schuchardt, C., Zachert, C., CARRIL, J. M., & Baum, R. P. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-2003-x · Cited by 62
68 Ga Small Peptide Imaging: Comparison of NOTA and PCTA
Ferreira, C. L., Yapp, D. T. T., Mandel, D., Gill, R. K., Boros, E., Wong, M. Q., Jurek, P. E., & Kiefer, G. E. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300348d · Cited by 62
Koumarianou, E., Loktionova, N. S., Fellner, M., Roesch, F., Thews, O., Pawlak, D., Archimandritis, S. C., & Mikołajczak, R. (2012) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2012.08.004 · Cited by 61
Introduction of Functional Groups into Peptides via N-Alkylation
Demmer, O., Dijkgraaf, I., Schottelius, M., Wester, H. J., & Kessler, H. (2008) · Organic Letters · doi:10.1021/ol800654n · Cited by 60
68Ga-DOTA-RGD peptide: biodistribution and binding into atherosclerotic plaques in mice
Haukkala, J., Laitinen, I., Luoto, P., Iveson, P. B., Wilson, I., Karlsen, H., Cuthbertson, A., Laine, J., Leppänen, P., Ylä‐Herttuala, S., et al. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1220-z · Cited by 58
Molecular Imaging and Contrast Agent Database (MICAD): Evolution and Progress
Chopra, A., Shan, L., Eckelman, W. C., Leung, K., Latterner, M., Bryant, S. H., & Menkens, A. E. (2011) · Molecular Imaging and Biology · doi:10.1007/s11307-011-0521-3 · Cited by 57
Lankinen, P., Mäkinen, T. J., Pöyhönen, T. A., Virsu, P., Salomäki, S., Hakanen, A., Jalkanen, S., Aro, H. T., & Roivainen, A. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0637-5 · Cited by 55
68Ga-labelled peptides in the management of neuroectodermal tumours
Naji, M., & AL-NAHHAS, A. M. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1990-y · Cited by 54
The Evolution of Imaging in Cancer: Current State and Future Challenges
Higgins, L., & Pomper, M. G. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.11.010 · Cited by 54
Fani, M., Tamma, M., Nicolas, G. P., Lasri, E., Medina, C., Raynal, I., Port, M., Weber, W., & Maëcke, H. R. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200418f · Cited by 54
Jacobsson, H., Larsson, P., Jonsson, C., Jussing, E., & Grybäck, P. (2012) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3182485110 · Cited by 53
Site-specific 68Ga-labeled Annexin A5 as a PET imaging agent for apoptosis
Bauwens, M., Saint‐Hubert, M. D., Devos, E., Deckers, N. M., Reutelingsperger, C. P. M., Mortelmans, L. A., Himmelreich, U., Mottaghy, F. M., & Verbruggen, A. (2010) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2010.09.008 · Cited by 52
Singh, A. N., Liu, W., Hao, G., Kumar, A., Gupta, A., Öz, O. K., Hsieh, J., & Sun, X. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200227d · Cited by 51
Giglio, J., Fernández, S., Pietzsch, H., Dematteis, S., Moreno, M., Pacheco, J. P., Cerecetto, H., & Rey, A. M. (2012) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2011.12.012 · Cited by 48
Chaves, S., Mendonça, A. C., Marques, S. M., Prata, M. I. M., SANTOS, A. C. D. S., Martins, A. F., Geraldes, C. F. G. C., & Santos, M. A. (2010) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2010.09.012 · Cited by 47
Radioguided Surgery in Neuroendocrine Tumors Using Ga-68-Labeled Somatostatin Analogs: A Pilot Study
Kaemmerer, D., Prasad, V., Daffner, W., Haugvik, S., Senftleben, S., Baum, R. P., & Hommann, M. (2012) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3182291de8 · Cited by 42
Lee, Y. K., Jeong, J. M., Hoigebazar, L., Yang, B., Lee, Y., Lee, B. C., Youn, H., Lee, D. S., Chung, J.-K., & Lee, M. C. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.092759 · Cited by 42
Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen
Hong, H., Sun, J., & Cai, W. (2008) · Biomarker Insights · doi:10.4137/bmi.s1124 · Cited by 41
Contribution of Imaging to Cancer Care Costs
Yang, Y., & Czernin, J. G. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.085621 · Cited by 39
Fani, M., Mueller, A., Tamma, M., Nicolas, G., Rink, H. R., Cescato, R., Reubi, J. C., & Maëcke, H. R. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.076695 · Cited by 39
Cantorias, M. V., Figueroa, S. D., Quinn, T. P., Lever, J. R., Hoffman, T. J., Watkinson, L. D., Carmack, T. L., & Cutler, C. S. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2009.01.017 · Cited by 38
Öberg, K. (2012) · Endocrine · doi:10.1007/s12020-012-9681-4 · Cited by 36
Ambrosini, V., Campana, D., Nanni, C., Cambioli, S., Tomassetti, P., Rubello, D., & Fanti, S. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2146-4 · Cited by 35
68Ga-Labeling of Biotin Analogues and their Characterization
Blom, E., Långström, B., & Velikyan, I. (2009) · Bioconjugate Chemistry · doi:10.1021/bc800538s · Cited by 34
Self-citationThews, O., Dillenburg, W., Fellner, M., Buchholz, H., Bausbacher, N., Schreckenberger, M., & Rösch, F. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1504-3 · Cited by 33
Ujula, T., Huttunen, M., Luoto, P., Peräkylä, H., Simpura, I., Wilson, I., Bergman, M., & Roivainen, A. (2010) · Bioconjugate Chemistry · doi:10.1021/bc1000643 · Cited by 31
Old and New Peptide Receptor Targets in Cancer: Future Directions
Reubi, J. C. (2012) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-27994-2_34 · Cited by 30
von Guggenberg, E., Rangger, C. A., Sosabowski, J. K., Laverman, P., Reubi, J., Virgolini, I. J., & Decristoforo, C. (2011) · Molecular Imaging and Biology · doi:10.1007/s11307-011-0506-2 · Cited by 30
Fernández, S., Dematteis, S., Giglio, J., Cerecetto, H., & Rey, A. M. (2012) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2012.11.003 · Cited by 29
Brom, M., Joosten, L., Laverman, P., Oyen, W. J. G., Béhé, M. P., Gotthardt, M., & Boerman, O. C. (2011) · Molecular Imaging · doi:10.2310/7290.2010.00032 · Cited by 27
Ring Size of Somatostatin Analogues (ODT-8) Modulates Receptor Selectivity and Binding Affinity
Érchegyi, J., Grace, C. R., Samant, M. P., Cescato, R., Piccand, V., Riek, R., Reubi, J. C., & Rivier, J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701444y · Cited by 27
Synthesis, radiometal labeling and in vitro evaluation of a targeted PPIX derivative
Azad, B. B., Cho, C., Lewis, J. D., & Luyt, L. G. (2011) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2011.11.054 · Cited by 27
Robust labeling and comparative preclinical characterization of DOTA-TOC and DOTA-TATE
Velikyan, I., Xu, H. M., Nair, M., & Hall, H. (2012) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2011.12.010 · Cited by 26
Self-citationLincke, T., Singer, J., Kluge, R., Sabri, O., & Paschke, R. (2009) · Thyroid · doi:10.1089/thy.2008.0389 · Cited by 24
Biodistribution of 68 Ga-Labeled LNA–DNA Mixmer Antisense Oligonucleotides for Rat Chromogranin-A
Lendvai, G., Velikyan, I., Estrada, S., Eriksson, B. K., Långström, B., & Bergström, M. (2008) · Oligonucleotides · doi:10.1089/oli.2007.0104 · Cited by 24
Self-citationEvaluation of 68Ga-labeled tracers for PET imaging of myocardial perfusion in pigs
Tarkia, M., Saraste, A., Saanijoki, T., Oikonen, V., Vähäsilta, T., Strandberg, M., Stark, C., Tolvanen, T., Teräs, M., Savunen, T., et al. (2012) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2011.11.007 · Cited by 24
Grace, C. R., Érchegyi, J., Samant, M. P., Cescato, R., Piccand, V., Riek, R., Reubi, J. C., & Rivier, J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701445q · Cited by 23
Cotugno, G., Aurilio, M., Annunziata, P., Capalbo, A., Faella, A., Rinaldi, V., Strisciuglio, C., Tommaso, M. D., Aloj, L., & Auricchio, A. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.098 · Cited by 23
Hicks, R. J. (2012) · Cancer Imaging · doi:10.1102/1470-7330.2012.9005 · Cited by 23
Karacay, H., Sharkey, R. M., McBride, W. J., Rossi, E. A., Chang, C., & Goldenberg, D. M. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.083568 · Cited by 23
Yim, C., van der Wildt, B., Dijkgraaf, I., Joosten, L., Eek, A., Versluis, C., Rijkers, D. T. S., Boerman, O. C., & Liskamp, R. M. J. (2011) · ChemBioChem · doi:10.1002/cbic.201000639 · Cited by 23
Ware, R. E., & Hicks, R. J. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.086611 · Cited by 18
Nuclear medicine imaging of neuroendocrine tumours
AL-NAHHAS, A. M. (2012) · Clinical Medicine · doi:10.7861/clinmedicine.12-4-377 · Cited by 16
Effects of posture on regional pulmonary blood flow in rats as measured by PET
Richter, T., Bergmann, R., Pietzsch, J., Közle, I., Hofheinz, F., Schiller, E., Ragaller, M., & van den Hoff, J. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91257.2008 · Cited by 15
Impurity in 68Ga-Peptide Preparation Using Processed Generator Eluate
Petřík, M., Ocak, M., Rupprich, M., et al. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.070953 · Cited by 13
How Does the Patient Benefit from Clinical PET?
Sørensen, J. C. H. (2012) · Theranostics · doi:10.7150/thno.3794 · Cited by 13
The Diversity of 68Ga-Based Imaging Agents
Velikyan, I. (2012) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-27994-2_7 · Cited by 12
Self-citationHow can we tell if PET imaging for cancer is cost effective?
MacManus, M. P., & Hicks, R. J. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70164-9 · Cited by 12
Hanin, F., Pauwels, S., Bol, A., Breeman, W. A. P., de Jong, M., & Jamar, F. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2009.09.006 · Cited by 12
Three‐dimensional consensus structure of sst2‐selective somatostatin (SRIF) antagonists by NMR
Grace, C. R., Érchegyi, J., Reubi, J. C., Rivier, J., & Riek, R. (2008) · Biopolymers · doi:10.1002/bip.21060 · Cited by 11
Exploring new frontiers in molecular imaging: Emergence of68Ga PET/CT
Tan, E. H., & Goh, S. W. (2010) · World Journal of Radiology · doi:10.4329/wjr.v2.i2.55 · Cited by 10
Cantorias, M. V., Quinn, T. P., Lever, J., Hoffman, T. J., Watkinson, L. D., Carmack, T. L., Figueroa, S. D., & Cutler, C. S. (2008) · Cancer Research · Cited by 9
Reply to: FDG PET and PET/CT: EANM procedure guideline for tumour PET imaging
imaging”, O. B. O. T. A. O. T. G. “. P. A. P. E. P. G. F. T. P., Boellaard, R., O’Doherty, M. J., Chiti, A., & Krause, B. J. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1459-4 · Cited by 8
Riet, J. V., Rattat, D., Verbruggen, A., Mortelmans, L. A., & Mottaghy, F. M. (2008) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e31818f4588 · Cited by 8
Sandström, K., Haylock, A.-K., Velikyan, I., Spiegelberg, D., Kareem, H., Максимилианович, Т. В., Lundqvist, H., & Nestor, M. (2011) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2011.0981 · Cited by 7
Self-citationWandering spleen on a 68Ga-DOTATOC-PET/CT scan
Lips, N., Deroose, C. M., Bielen, D., Bossuyt, P. J., & Mortelmans, L. A. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1714-8 · Cited by 7
Riss, P. J., Burchardt, C., Zimny, M., Peters, J. A., & Roesch, F. (2012) · RSC Advances · doi:10.1039/c2ra20931d · Cited by 6
Czernin, J. G., & Weber, W. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.097071 · Cited by 5
Alveolar Rhabdomyosarcoma With Neuroendocrine Differentiation Detected by Ga-68 DOTA-NOC PET/CT
Zanoni, L., Lopci, E., Ambrosini, V., Boschi, S., & Fanti, S. (2011) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e31821a2691 · Cited by 5
Cited by
Radioactive Main Group and Rare Earth Metals for Imaging and Therapy
Kostelnik, T. I., & Orvig, C. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00294 · Cited by 483
Physics of pure and non-pure positron emitters for PET: a review and a discussion
Conti, M., & Eriksson, L. (2016) · EJNMMI Physics · doi:10.1186/s40658-016-0144-5 · Cited by 393
68Ga-Based Radiopharmaceuticals: Production and Application Relationship
Velikyan, I. (2015) · Molecules · doi:10.3390/molecules200712913 · Cited by 255
Self-citation
Metadata
- Authors
- Velikyan, I.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2014
- Volume
- 4
- Issue
- 1
- Pages
- 47-80
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W1520088546
- Cited by
- 336
- References
- 186
- FWCI
- 28.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.